Naunyn-Schmiedeberg's Archives of Pharmacology

, Volume 368, Issue 2, pp 134–141 | Cite as

The effects of systemically administered taurine and N-pivaloyltaurine on striatal extracellular dopamine and taurine in freely moving rats

  • J. Salimäki
  • G. Scriba
  • T.  P.  Piepponen
  • N. Rautolahti
  • L. AhteeEmail author
Original Article


The second most abundant cerebral amino acid, taurine, is widely consumed in the so-called "energy drinks". Therefore, its possible actions on the brain are of great interest. In the present experiments taurine was given intraperitoneally to rats in order to study if it can be administered systemically in large enough amounts to alter cerebral dopaminergic transmission or to induce hypothermia. In addition, the effects of subcutaneously administered lipophilic taurine analogue, N-pivaloyltaurine, were studied. The extracellular striatal taurine and dopamine concentrations were estimated using in vivo microdialysis in awake and freely moving rats, and the rectal temperatures were measured. Taurine at the total dose of 45 mmol/kg i.p. led to a maximally 8-fold increased striatal extracellular taurine concentration, induced a long-lasting hypothermia, and significantly reduced the striatal extracellular dopamine concentration. The latter effect was strengthened by co-treatment with reuptake inhibitor nomifensine. N-pivaloyltaurine (15 mmol/kg in total, s.c.) only slightly elevated the striatal extracellular taurine concentration, failed to alter the rectal temperature, and in contrast to taurine somewhat elevated the striatal extracellular dopamine concentration suggesting a different mechanism or locus of action from that of taurine. Finally, our experiments using brain microdialysis confirmed the earlier findings that taurine is slowly eliminated from the brain. The results clearly indicate that systemically given taurine enters the brain in concentrations that induce pharmacological effects.


Taurine  N-pivaloyltaurine Dopamine  Striatum Systemic administration Hypothermia In vivo microdialysis 



We thank Marjo Vaha for her invaluable technical assistance.


  1. Ahtee L, Vahala M-L (1985) Taurine and its derivatives alter brain dopamine metabolism similarly to GABA in mice and rats. In: Oja SS, Ahtee L, Kontro P, Paasonen MK (eds) Taurine: biological actions and clinical perspectives. Liss, New York, pp 331–341Google Scholar
  2. Ahtee L, Auvinen H, Mäenpää A-R, Vahala M-L, Lehtinen M, Halmekoski J (1985) Comparison of central nervous system actions of taurine and N-pivaloyltaurine. Acta Pharmacol Toxicol 57:96–105Google Scholar
  3. Aldegunde M, Miguez I, Martin I, Fernandez Otero MP (1983) Changes in brain monoamine metabolism associated with hypothermia induced by intraperitoneally administered taurine in the rat. IRCS Med Sci 11:258–259Google Scholar
  4. Alford C, Cox H, Wescott R (2001) The effects of Red Bull Energy Drink on human performance and mood. Amino Acids 21:139–150CrossRefPubMedGoogle Scholar
  5. Anderson JJ, DiMicco JA (1992) The use of microdialysis for studying the regional effects of pharmacological manipulation on extracellular levels of amino acids—some methodological aspects. Life Sci 51:623–630CrossRefPubMedGoogle Scholar
  6. Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB (1988) Systemic approaches to modifying quinolinic acid striatal lesions in rats. J Neurosci 8:3901–3908PubMedGoogle Scholar
  7. Bianchi L, Bolam JP, Galeffi F, Frosini M, Palmi M, Sgaragli G, Della Corte L (1996) In vivo release of taurine from rat neostriatum and substantia nigra. In: Huxtable RJ, Azuma J, Kuriyama K, Nakagawa M, Baba A (eds) Taurine 2: basic and clinical aspects. Plenum, New York, pp 427–433Google Scholar
  8. Böckelmann R, Reiser M, Wolf G (1998) Potassium-stimulated taurine release and nitric oxide synthase activity during quinolinic acid lesion of the rat striatum. Neurochem Res 23:469–475CrossRefPubMedGoogle Scholar
  9. Bureau MH, Olsen WO (1991) Taurine acts on a subclass of GABAA receptors in mammalian brain in vitro. Eur J Pharmacol 27:9–16Google Scholar
  10. Butcher SP, Liptrot J, Arbuthnott GW (1991) Characterisation of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci Lett 122:245–248CrossRefPubMedGoogle Scholar
  11. Collins GGS (1974) The rates of synthesis, uptake and disappearance of [14C]-taurine in eight areas of the rat central nervous system. Brain Res 76:447–459CrossRefPubMedGoogle Scholar
  12. Dykstra KH, Hsiao JK, Morrison PF, Bungay PM, Mefford IN, Scully MM, Dedrick RL (1992) Quantitative examination of tissue concentration profiles associated with microdialysis. J Neurochem 58:931–940PubMedGoogle Scholar
  13. Eppler B, Patterson TA, Zhou W, Millard WJ, Dawson R Jr (1999) Kainic acid (KA)-induced seizures in Sprague-Dawley rats and the effect of dietary taurine (TAU) supplementation or deficiency. Amino Acids 16:133–147PubMedGoogle Scholar
  14. Ganong WF (1995) In: Review of medical physiology. Appleton and Lange, New York, pp 560Google Scholar
  15. Garcia de Yebenes Prous J, Carlsson A, Mena Gomez MA (1978) The effect of taurine on motor behaviour, body temperature and monoamine metabolism in rat brain. Naunyn-Schmiedebergs Arch Pharmacol 304:95–99Google Scholar
  16. Glyn JR, Lipton JM (1981) Effects of central administration of alanine on body temperature of the rabbit: comparisons with the effects of serine, glycine and taurine. Brain Res Bull 6:467–472PubMedGoogle Scholar
  17. Greubel S (1998) Isotonische Getränke, "energy"- und "power"-drinks. Med Monatschr Pharm 21:353–355Google Scholar
  18. Haas HL, Hösli L (1973) The depression of brain stem neurones by taurine and its interaction with strychnine and bicuculline. Brain Res 52:399–402CrossRefPubMedGoogle Scholar
  19. Hashimoto-Kitsukawa S, Okuyama S, Aihara H (1988) Enhancing effect of taurine on the rat caudate spindle. I. Interaction of taurine with the nigro-striatal dopamine system. Pharmacol Biochem Behav 31:411–416CrossRefPubMedGoogle Scholar
  20. Häusser MA, Yung WH, Lacey MG (1992) Taurine and glycine activate the same Cl conductance in substantia nigra dopamine neurones. Brain Res 571:103–108CrossRefPubMedGoogle Scholar
  21. Hilgier W, Zielinska M, Borkowska HD, Gadamski R, Walski M, Oja SS, Saransaari P, Albrecht J (1999) Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure. J Neurosci Res 56:76–84CrossRefPubMedGoogle Scholar
  22. Horikoshi T, Asanuma A, Yanagisawa K, Anzai K, Goto S (1988) Taurine and β-alanine act on both GABA and glycine receptors in Xenopus oocyte injected with mouse brain messenger RNA. Mol Brain Res 4:97–105CrossRefGoogle Scholar
  23. Huber JD, Egleton RD, Davis TP (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24:719–725CrossRefPubMedGoogle Scholar
  24. Huxtable RJ (1989) Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 32:471–533CrossRefPubMedGoogle Scholar
  25. Kontro P, Oja SS (1990) Interactions of taurine with GABAB binding sites in mouse brain. Neuropharmacology 29:243–247CrossRefPubMedGoogle Scholar
  26. Missale C, Castelletti L, Govoni S, Spano PF, Trabucchi M, Hanbauer I (1985) Dopamine uptake is differentially regulated in rat striatum and nucleus accumbens. J Neurochem 45:51–56PubMedGoogle Scholar
  27. O'Neill R (1986) Effects of intranigral injection of taurine and GABA on striatal dopamine release monitored voltammetrically in the unanaesthetized rat. Brain Res 382:28–32CrossRefPubMedGoogle Scholar
  28. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic, New YorkGoogle Scholar
  29. Piepponen TP, Skujins A (2001) Rapid and sensitive step gradient assays of glutamate, glycine, taurine and γ-aminobutyric acid by high-performance liquid chromatography—fluorescence detection with o-phthalaldehyde-mercaptoethanol derivatization with an emphasis on microdialysis samples. J Chromatogr B 757:277–283CrossRefGoogle Scholar
  30. Quinn MR, Harris CL (1995) Taurine allosterically inhibits binding of [35S]-t-butylbicyclophosphorothionate (TBPS) to rat brain synaptic membranes. Neuropharmacology 34:1607–1613CrossRefPubMedGoogle Scholar
  31. Riesselmann B, Rosenbaum F, Schneider V (1996) Alkohol und energy drink—kann der gemeinsame Konsum beider Getränke die Fahrtüchtigkeit beeinträchtigen? Blutalkohol 33:201–208Google Scholar
  32. Roth RH, Murrin LC, Walters JR (1976) Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. Eur J Pharmacol 36:163–171CrossRefPubMedGoogle Scholar
  33. Ruotsalainen M, Ahtee L (1996) Intrastriatal taurine increases striatal extracellular dopamine in a tetrodotoxin-sensitive manner in rats. Neurosci Lett 212:175–178CrossRefPubMedGoogle Scholar
  34. Ruotsalainen M, Heikkilä M, Lillsunde P, Seppälä T, Ahtee L (1996) Taurine infused intrastriatally elevates, but intranigrally decreases striatal extracellular dopamine concentration in anaesthetised rats. J Neural Transm 103:935–946PubMedGoogle Scholar
  35. Ruotsalainen M, Majasaari M, Salimäki J, Ahtee L (1998) Locally infused taurine, GABA and homotaurine alter differentially the striatal extracellular concentrations of dopamine and its metabolites in rats. Amino Acids 15:117–134PubMedGoogle Scholar
  36. Seidl R, Peyrl A, Nicham R, Hauser E (2000) A taurine and caffeine-containing drink stimulates cognitive performance and well-being. Amino Acids 19:635–642PubMedGoogle Scholar
  37. Semba J, Kito S, Toru M (1995) Characterisation of extracellular amino acids in striatum of freely moving rats by in vivo microdialysis. J Neural Transm 100:39–52Google Scholar
  38. Sgaragli GP, Pavàn F, Galli A (1975) Is taurine-induced hypothermia in the rat mediated by 5-HT? Naunyn-Schmiedebergs Arch Pharmacol 288:179–184Google Scholar
  39. Sgaragli GP, Carlà V, Magnani M, Giotti A (1978) Homotaurine and muscimol mimic taurine and GABA effects on muscle tone and temperature regulation. Naunyn-Schmiedebergs Arch Pharmacol 305:155–158Google Scholar
  40. Tossman U, Jonsson G, Ungerstedt U (1986) Regional distribution and extracellular levels of amino acids in rat central nervous system. Acta Physiol Scand 127:533–545PubMedGoogle Scholar
  41. Toth E, Lajtha A (1981) Elevation of cerebral levels of nonessential amino acids in vivo by administration of large doses. Neurochem Res 6:1309–1317PubMedGoogle Scholar
  42. Van Gelder NM, Bowers RJ (2001) Synthesis and characterization of N,N-dichlorinated amino acids: taurine, homotaurine, GABA and L-leucine. Neurochem Res 26:575–578CrossRefPubMedGoogle Scholar
  43. Wahl P, Elster L, Schousboe A (1994) Identification and function of glycine receptors in cultured cerebellar granule cells. J Neurochem 62:2457–2463PubMedGoogle Scholar
  44. Walters JR, Roth RH (1974) Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow. J Pharmacol Exp Ther 191:82–91PubMedGoogle Scholar
  45. Westergren I, Nyström B, Hamberger A, Johansson BB (1995) Intracerebral dialysis and the blood-brain barrier. J Neurochem 64:229–234PubMedGoogle Scholar
  46. Wu J-Y, Tang XW, Tsai WH (1992) Taurine receptor: kinetic analysis and pharmacological studies. In: Lombardini JB, Schaffer SW, Azuma J (eds) Taurine: nutritional value and mechanisms of action. Plenum, New York, pp 263–268Google Scholar
  47. Yakimova K, Ovtcharov R (1989) Central temperature effects of the transmitter amino acids. Acta Physiol Pharmacol Bulg 15:50–53PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2003

Authors and Affiliations

  • J. Salimäki
    • 1
  • G. Scriba
    • 2
  • T.  P.  Piepponen
    • 1
  • N. Rautolahti
    • 1
  • L. Ahtee
    • 1
    Email author
  1. 1.Department of Pharmacy, Division of Pharmacology and ToxicologyUniversity of HelsinkiHelsinkiFinland
  2. 2.Department of Pharmaceutical ChemistryUniversity of JenaJenaGermany

Personalised recommendations